BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 31089208)

  • 1. The anaphase-promoting complex/cyclosome: a new promising target in diffuse large B-cell lymphoma and mantle cell lymphoma.
    Maes A; Maes K; De Raeve H; De Smedt E; Vlummens P; Szablewski V; Devin J; Faict S; De Veirman K; Menu E; Offner F; Spaargaren M; Moreaux J; Vanderkerken K; Van Valckenborgh E; De Bruyne E
    Br J Cancer; 2019 Jun; 120(12):1137-1146. PubMed ID: 31089208
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting the anaphase promoting complex/cyclosome induces a metaphase arrest and cell death in multiple myeloma cells.
    Lub S; Maes A; Maes K; De Veirman K; De Bruyne E; Menu E; Fostier K; Kassambara A; Moreaux J; Hose D; Leleu X; King RW; Vanderkerken K; Van Valckenborgh E
    Oncotarget; 2016 Jan; 7(4):4062-76. PubMed ID: 26716651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Maternal embryonic leucine zipper kinase is a novel target for diffuse large B cell lymphoma and mantle cell lymphoma.
    Maes A; Maes K; Vlummens P; De Raeve H; Devin J; Szablewski V; De Veirman K; Menu E; Moreaux J; Vanderkerken K; De Bruyne E
    Blood Cancer J; 2019 Nov; 9(12):87. PubMed ID: 31740676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular mechanism of APC/C activation by mitotic phosphorylation.
    Zhang S; Chang L; Alfieri C; Zhang Z; Yang J; Maslen S; Skehel M; Barford D
    Nature; 2016 May; 533(7602):260-264. PubMed ID: 27120157
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the APC/C co-factor FZR1 as a novel therapeutic target for multiple myeloma.
    Crawford LJ; Anderson G; Johnston CK; Irvine AE
    Oncotarget; 2016 Oct; 7(43):70481-70493. PubMed ID: 27655696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Bruton tyrosine kinase (BTK) inhibitor PCI-32765 synergistically increases proteasome inhibitor activity in diffuse large-B cell lymphoma (DLBCL) and mantle cell lymphoma (MCL) cells sensitive or resistant to bortezomib.
    Dasmahapatra G; Patel H; Dent P; Fisher RI; Friedberg J; Grant S
    Br J Haematol; 2013 Apr; 161(1):43-56. PubMed ID: 23360303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequestration of CDH1 by MAD2L2 prevents premature APC/C activation prior to anaphase onset.
    Listovsky T; Sale JE
    J Cell Biol; 2013 Oct; 203(1):87-100. PubMed ID: 24100295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategic Therapeutic Targeting to Overcome Venetoclax Resistance in Aggressive B-cell Lymphomas.
    Pham LV; Huang S; Zhang H; Zhang J; Bell T; Zhou S; Pogue E; Ding Z; Lam L; Westin J; Davis RE; Young KH; Medeiros LJ; Ford RJ; Nomie K; Zhang L; Wang M
    Clin Cancer Res; 2018 Aug; 24(16):3967-3980. PubMed ID: 29666304
    [No Abstract]   [Full Text] [Related]  

  • 9. Hyperphosphorylation of CDH1 in Glioblastoma Cancer Stem Cells Attenuates APC/C
    De K; Grubb TM; Zalenski AA; Pfaff KE; Pal D; Majumder S; Summers MK; Venere M
    Mol Cancer Res; 2019 Jul; 17(7):1519-1530. PubMed ID: 31036696
    [TBL] [Abstract][Full Text] [Related]  

  • 10. APC/C ubiquitin ligase: Functions and mechanisms in tumorigenesis.
    Schrock MS; Stromberg BR; Scarberry L; Summers MK
    Semin Cancer Biol; 2020 Dec; 67(Pt 2):80-91. PubMed ID: 32165320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diffuse large B-cell lymphoma and mantle cell lymphoma of the ocular adnexal region, and lymphoma of the lacrimal gland: an investigation of clinical and histopathological features.
    Rasmussen PK
    Acta Ophthalmol; 2013 Jul; 91 Thesis 5():1-27. PubMed ID: 24041159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic blockade of mitotic exit by two chemical inhibitors of the APC/C.
    Sackton KL; Dimova N; Zeng X; Tian W; Zhang M; Sackton TB; Meaders J; Pfaff KL; Sigoillot F; Yu H; Luo X; King RW
    Nature; 2014 Oct; 514(7524):646-9. PubMed ID: 25156254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The regulation of Cdc20 proteolysis reveals a role for APC components Cdc23 and Cdc27 during S phase and early mitosis.
    Prinz S; Hwang ES; Visintin R; Amon A
    Curr Biol; 1998 Jun; 8(13):750-60. PubMed ID: 9651679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. APC/C
    Zhang M; Yao F; Luan H; Zhao W; Jing T; Zhang S; Hou L; Zou X
    Sci Rep; 2016 Dec; 6():39047. PubMed ID: 27991546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reciprocal interaction between SIRT6 and APC/C regulates genomic stability.
    Wang H; Feng K; Wang Q; Deng H
    Sci Rep; 2021 Jul; 11(1):14253. PubMed ID: 34244565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cdh1 is an antagonist of the spindle assembly checkpoint.
    Nagai M; Ushimaru T
    Cell Signal; 2014 Oct; 26(10):2217-22. PubMed ID: 25025567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ProTAME Arrest in Mammalian Oocytes and Embryos Does Not Require Spindle Assembly Checkpoint Activity.
    Radonova L; Svobodova T; Skultety M; Mrkva O; Libichova L; Stein P; Anger M
    Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31540287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cyclin B3 activates the Anaphase-Promoting Complex/Cyclosome in meiosis and mitosis.
    Garrido D; Bourouh M; Bonneil É; Thibault P; Swan A; Archambault V
    PLoS Genet; 2020 Nov; 16(11):e1009184. PubMed ID: 33137813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms.
    Nguyen T; Parker R; Zhang Y; Hawkins E; Kmieciak M; Craun W; Grant S
    BMC Cancer; 2018 Nov; 18(1):1129. PubMed ID: 30445933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peptide inhibitors of the anaphase promoting-complex that cause sensitivity to microtubule poison.
    Schuyler SC; Wu YO; Chen HY; Ding YS; Lin CJ; Chu YT; Chen TC; Liao L; Tsai WW; Huang A; Wang LI; Liao TW; Jhuo JH; Cheng V
    PLoS One; 2018; 13(6):e0198930. PubMed ID: 29883473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.